loading
Schlusskurs vom Vortag:
$3.70
Offen:
$3.68
24-Stunden-Volumen:
2.15M
Relative Volume:
1.06
Marktkapitalisierung:
$618.92M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.2911
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
-2.70%
1M Leistung:
+9.39%
6M Leistung:
-19.42%
1J Leistung:
-56.06%
1-Tages-Spanne:
Value
$3.54
$3.75
1-Wochen-Bereich:
Value
$3.54
$3.88
52-Wochen-Spanne:
Value
$1.775
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
399 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
259
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RLAY
Relay Therapeutics Inc
3.61 641.20M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
467.34 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.53 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.59 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
596.80 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.41 31.54B 3.81B -644.79M -669.77M -6.24

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet Wells Fargo Equal Weight
2024-09-10 Fortgesetzt Goldman Buy
2024-09-10 Hochstufung Jefferies Hold → Buy
2024-09-10 Herabstufung Oppenheimer Outperform → Perform
2024-05-10 Hochstufung Barclays Equal Weight → Overweight
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
09:56 AM

Relay Therapeutics has positive read from Celcuity data, says Barclays - Yahoo Finance

09:56 AM
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Relay Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Relay Therapeutics Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Price Floor Holding on Relay Therapeutics Inc. — Rebound PossibleProfit Focused Stock Screener Results Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Relay Therapeutics Inc. stock attracting strong analyst attentionAchieve breakthrough profits with smart strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Relay Therapeutics Inc. company’s key revenue driversGet expert analysis on top stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Does Relay Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Relay Therapeutics Inc. compare to its industry peersMaximize gains with proven stock analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Relay Therapeutics Inc. a growth stock or a value stockGet daily updates on the hottest stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Invest in high-yield stocks with confidence - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Relay Therapeutics Inc.Build wealth steadily with smart stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Relay Therapeutics Inc. stock overvalued or undervaluedExceptional stock performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Why Relay Therapeutics Inc. stock attracts strong analyst attentionCapital Efficient Investment Tips - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Relay Therapeutics Inc. stockExceptional growth trajectory - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Is Relay Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

When is the best time to buy Relay Therapeutics Inc. stockFree Consultation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Relay Therapeutics Inc. stock priceTremendous growth potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

what makes relay therapeutics inc. stock price move sharplyTargeted 200 Percent Gain - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock overhyped or has real potentialLong Term Secure Gain Stocks - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser

Jul 18, 2025

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Rahmer Peter
See remarks
Apr 30 '25
Sale
3.00
10,739
32,217
390,081
Rahmer Peter
See remarks
Apr 28 '25
Sale
3.17
1,364
4,324
400,820
Catinazzo Thomas
Chief Financial Officer
Apr 30 '25
Sale
3.00
12,943
38,829
355,376
Catinazzo Thomas
Chief Financial Officer
Apr 29 '25
Sale
3.23
3,558
11,492
368,319
Catinazzo Thomas
Chief Financial Officer
Apr 28 '25
Sale
3.17
2,690
8,527
371,877
Bergstrom Donald A
President, R&D
Apr 30 '25
Sale
3.00
27,472
82,416
583,490
Bergstrom Donald A
President, R&D
Apr 28 '25
Sale
3.17
4,090
12,965
610,962
Adams Brian
Chief Legal Officer
Apr 30 '25
Sale
3.00
12,943
38,829
391,385
Adams Brian
Chief Legal Officer
Apr 28 '25
Sale
3.17
1,644
5,211
404,328
$76.42
price up icon 8.87%
$37.41
price up icon 0.94%
$104.18
price up icon 2.40%
$26.82
price down icon 2.13%
$110.33
price down icon 2.19%
biotechnology ONC
$305.38
price up icon 3.60%
Kapitalisierung:     |  Volumen (24h):